Jinhai Medical Technology Limited

SEHK:2225 Rapporto sulle azioni

Cap. di mercato: HK$7.9b

Jinhai Medical Technology Gestione

Gestione criteri di controllo 3/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Zhenfei Wang

Amministratore delegato

S$111.0k

Compenso totale

Percentuale dello stipendio del CEO97.3%
Mandato del CEO5.3yrs
Proprietà del CEOn/a
Durata media del management1.3yrs
Durata media del Consiglio di amministrazione5.3yrs

Aggiornamenti recenti sulla gestione

The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Jun 19
The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Recent updates

Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

Oct 06
Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Jun 19
The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

May 13
Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

Mar 17
Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Jan 31
What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Jun 06
Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Mar 07
Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Zhenfei Wang rispetto agli utili di Jinhai Medical Technology?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-S$10m

Mar 31 2024n/an/a

-S$7m

Dec 31 2023S$111kS$108k

-S$3m

Sep 30 2023n/an/a

-S$2m

Jun 30 2023n/an/a

S$6k

Mar 31 2023n/an/a

S$237k

Dec 31 2022S$240kS$237k

S$468k

Sep 30 2022n/an/a

S$443k

Jun 30 2022n/an/a

S$419k

Mar 31 2022n/an/a

S$86k

Dec 31 2021S$356kS$353k

-S$246k

Sep 30 2021n/an/a

S$320k

Jun 30 2021n/an/a

S$852k

Mar 31 2021n/an/a

S$1m

Dec 31 2020S$365kS$362k

S$1m

Sep 30 2020n/an/a

S$516k

Jun 30 2020n/an/a

-S$231k

Mar 31 2020n/an/a

-S$459k

Dec 31 2019S$362kS$161k

-S$686k

Compensazione vs Mercato: Zhenfei's total compensation ($USD84.37K) is below average for companies of similar size in the Hong Kong market ($USD495.13K).

Compensazione vs guadagni: Zhenfei's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Zhenfei Wang (43 yo)

5.3yrs

Mandato

S$111,000

Compensazione

Mr. Zhenfei Wang has been Chief Executive Officer and Executive Director of Jinhai Medical Technology Limited (formerly known as Jinhai International Group Holdings Limited) (formerly known as Kakiko Group...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Guobao Chen
Executive Chairman of the Board5.3yrsS$337.00k48.94%
HK$ 3.9b
Zhenfei Wang
CEO & Executive Director5.3yrsS$111.00kNessun dato
Yunping Li
Executive Director1.3yrsS$86.00kNessun dato
Man Yiu Wong
Chief Financial Officer5yrsNessun datoNessun dato
Lei Liu
Chief Technical Officerless than a yearNessun datoNessun dato
Xiao He
Chief Marketing Officerless than a yearNessun datoNessun dato
Yuen Cheng
Company Secretaryless than a yearNessun datoNessun dato

1.3yrs

Durata media

50.5yo

Età media

Gestione esperta: 2225's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Guobao Chen
Executive Chairman of the Board5.3yrsS$337.00k48.94%
HK$ 3.9b
Zhenfei Wang
CEO & Executive Director5.3yrsS$111.00kNessun dato
Yunping Li
Executive Director5.3yrsS$86.00kNessun dato
Mingyang Yu
Non-Executive Director1.3yrsS$13.00kNessun dato
Huasheng Wang
Non-Executive Director5.3yrsS$33.00kNessun dato
Jianjun Yan
Independent Non-Executive Director5.3yrsS$21.00kNessun dato
Yimin Fan
Independent Non-Executive Director5.3yrsS$21.00kNessun dato
Meihua Yang
Independent Non-Executive Director2.8yrsS$21.00kNessun dato

5.3yrs

Durata media

58.5yo

Età media

Consiglio di amministrazione esperto: 2225's board of directors are considered experienced (5.3 years average tenure).